Trevena Inc. [NASDAQ: TRVN] stock went on an upward path that rose over 14.40% on Thursday, amounting to a one-week price increase of more than 2.14%. The company report on July 26, 2021 that Trevena Announces First Patient Enrolled in NIH-Funded ACTIV-4 Host Tissue Trial of TRV027 for COVID-19.
TRV027 will be dosed in ~300 patients in nationwide trial led by Vanderbilt University Medical Center (VUMC).
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, announced that the first COVID-19 patient has been enrolled in the NIH-funded ACTIV-4 Host Tissue (Accelerating COVID-19 Therapeutic Interventions and Vaccines) trial.
Over the last 12 months, TRVN stock dropped by -45.63%. The average equity rating for TRVN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $247.62 million, with 163.59 million shares outstanding and 162.06 million shares in the current float. Compared to the average trading volume of 2.55M shares, TRVN stock reached a trading volume of 4545064 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Trevena Inc. [TRVN]:
Oppenheimer have made an estimate for Trevena Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on March 15, 2021. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on September 14, 2020, representing the official price target for Trevena Inc. stock. Previously, the target price had yet another raise to $5, while Cantor Fitzgerald analysts kept a Overweight rating on TRVN stock.
The Average True Range (ATR) for Trevena Inc. is set at 0.10, with the Price to Sales ratio for TRVN stock in the period of the last 12 months amounting to 75.04. The Price to Book ratio for the last quarter was 2.34.
TRVN Stock Performance Analysis:
Trevena Inc. [TRVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.14. With this latest performance, TRVN shares dropped by -11.18% in over the last four-week period, additionally sinking by -45.21% over the last 6 months – not to mention a drop of -45.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRVN stock in for the last two-week period is set at 44.26, with the RSI for the last a single of trading hit 48.22, and the three-weeks RSI is set at 43.03 for Trevena Inc. [TRVN]. The present Moving Average for the last 50 days of trading for this stock 1.6988, while it was recorded at 1.3460 for the last single week of trading, and 2.0446 for the last 200 days.
Insight into Trevena Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Trevena Inc. [TRVN] shares currently have an operating margin of -960.74 and a Gross Margin at +67.03. Trevena Inc.’s Net Margin is presently recorded at -956.96.
Return on Total Capital for TRVN is now -37.94, given the latest momentum, and Return on Invested Capital for the company is -39.41. Return on Equity for this stock declined to -43.79, with Return on Assets sitting at -33.62. When it comes to the capital structure of this company, Trevena Inc. [TRVN] has a Total Debt to Total Equity ratio set at 7.50. Additionally, TRVN Total Debt to Total Capital is recorded at 6.98, with Total Debt to Total Assets ending up at 6.11. Long-Term Debt to Equity for the company is recorded at 6.82, with the Long-Term Debt to Total Capital now at 6.35.
Reflecting on the efficiency of the workforce at the company, Trevena Inc. [TRVN] managed to generate an average of -$1,174,760 per employee. Receivables Turnover for the company is 86.45 with a Total Asset Turnover recorded at a value of 0.04.Trevena Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.10 and a Current Ratio set at 8.10.
Trevena Inc. [TRVN] Insider Position Details
There are presently around $40 million, or 17.20% of TRVN stock, in the hands of institutional investors. The top three institutional holders of TRVN stocks are: VANGUARD GROUP INC with ownership of 7,122,157, which is approximately 0.621% of the company’s market cap and around 1.30% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 3,811,691 shares of the stock with an approximate value of $5.45 million in TRVN stocks shares; and BLACKROCK INC., currently with $4.96 million in TRVN stock with ownership of nearly 31.938% of the company’s market capitalization.
Positions in Trevena Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 47 institutional holders increased their position in Trevena Inc. [NASDAQ:TRVN] by around 7,316,150 shares. Additionally, 29 investors decreased positions by around 2,175,488 shares, while 23 investors held positions by with 18,527,224 shares. The mentioned changes placed institutional holdings at 28,018,862 shares, according to the latest SEC report filing. TRVN stock had 22 new institutional investments in for a total of 1,511,570 shares, while 10 institutional investors sold positions of 194,249 shares during the same period.